Rotavirus Infection in Infants Protects Substantially Against Reinfection

Vaccination News Home Page

http://www.medscape.com/viewarticle/440656?mpid=3145&WebLogicSession=PXwm3H3Gns7Apouev2oLm4YlBjzbzuYgoz8mbI1SGgWRkZunlKMW|-1468812056489609316/184161392/6/7001/7001/7002/7002/7001/-1

Medscape

 
My Home Page Shortcuts Check Mail Account Settings Log Out REGISTRATION SignIn
MEDLINE Drug Info More...
BROWSE
SEARCH



 

Welcome, S M



HomeCME CenterConference CenterLibraryDiscussionsMarketplaceHelp September 9, 2002  
Email to a Colleague Printable Version Add to My Shortcuts
Publication Logo
Rotavirus Infection in Infants Protects Substantially Against Reinfection


 

 


 

NEW YORK (Reuters Health) Aug 27 - Natural rotavirus infection appears to confer considerable protection against subsequent rotavirus reinfection and diarrhea, according to a report in the September 1st issue of The Journal of Infectious Diseases.

Dr. Thea K. Fischer, of the University of Bergen, Norway, and colleagues prospectively followed 200 newborns in Guinea-Bissau for up to 2 years using weekly stool examination to detect rotavirus.

The incidence of rotavirus infection by ages 6 months, 1 year, and 2 years was 26%, 46%, and 74%, respectively. Diarrhea occurred in association with 17% of rotavirus infections in the first 3 months of life and with 60% of infections by 9 to 11 months of age. All rotavirus infections were asymptomatic after age 18 months.

Natural rotavirus infection conferred 52% protection against reinfection and 70% protection against rotavirus diarrhea, the team reports. "The protection estimates against reinfection within the same epidemic and in any subsequent epidemic were 66% and 34%, respectively," they add.

Dr. Fischer and colleagues conclude that the "high level of protection against symptomatic rotavirus infection provides an important incentive for development of a rotavirus vaccine."

J Infect Dis 2002;186:593-597.

 

 


 

   

Reuters Health Information 2002. © 2002 Reuters Ltd.
Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.



 

 


 


 

 


 


Related Resources
 
Clinical articles on this topic

Keyword Search   Advanced Search
 
Medscape  DrugInfo 
Patient Info    MEDLINE 
About Medscape  Privacy & Ethics  Terms of Use  Help

All material on this website is protected by copyright, Copyright © 1994-2002 by Medscape. This website also contains material copyrighted by 3rd parties. Medscape requires 4.x browsers or better from Netscape or Microsoft.

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.